CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 97  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0912
LYS 10.0032
GLU 20.0112
LEU 30.0161
ARG 40.0157
CYS 50.0077
GLN 60.0146
CYS 70.0087
ILE 80.0117
LYS 90.0102
THR 100.0124
TYR 110.0208
SER 120.0495
LYS 130.0912
PRO 140.0375
PHE 150.0167
HIS 160.0142
PRO 170.0154
LYS 180.0228
PHE 190.0104
ILE 200.0007
LYS 210.0145
GLU 220.0083
LEU 230.0169
ARG 240.0195
VAL 250.0168
ILE 260.0082
GLU 270.0138
SER 280.0124
GLY 290.0180
PRO 300.0138
HIS 310.0057
CYS 320.0034
ALA 330.0180
ASN 340.0088
THR 350.0083
GLU 360.0084
ILE 370.0127
ILE 380.0087
VAL 390.0143
LYS 400.0114
LEU 410.0083
SER 420.0164
ASP 430.0818
GLY 440.0227
ARG 450.0300
GLU 460.0075
LEU 470.0085
CYS 480.0106
LEU 490.0132
ASP 500.0370
PRO 510.0110
LYS 520.0555
GLU 530.0216
ASN 540.0152
TRP 550.0079
VAL 560.0053
GLN 570.0102
ARG 580.0123
VAL 590.0062
VAL 600.0065
GLU 610.0111
LYS 620.0071
PHE 630.0026
LEU 640.0049
LYS 650.0233
ARG 660.0206
ALA 670.0451
GLU 680.0240
ASN 690.0206

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.